Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-09-19T00:15:57.670Z.
Calculation as of: 2026-09-19T00:15:57.670Z.
Quote observation: 2026-09-18T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9edfc78ac10ef3c00dfd6e8891c60c5ddca660cc4cfb74c64a12c551c30ed6c4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Market Cap
$1.91B
EV/FCF Ratio
27.86x
TTM Avg
44.20x
3Y Avg
32.95x
5Y Avg
28.98x
Market Cap
$2.99B
EV/FCF Ratio
42.79x
TTM Avg
70.56x
3Y Avg
92.49x
5Y Avg
92.49x
Market Cap
$5.10B
EV/FCF Ratio
26.87x
TTM Avg
21.51x
3Y Avg
36.54x
5Y Avg
41.31x
Market Cap
$5.59B
EV/FCF Ratio
N/A
TTM Avg
29.52x
3Y Avg
29.52x
5Y Avg
29.52x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | $376.61M | N/A | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $463.35M | 25.42x | 34.05x | 32.65x | 32.12x |
| PDS Biotechnology Corporation (PDSB)vs › | $45.05M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.14B | 6.26x | 6.97x | 8.64x | 16.12x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.91B | 27.86x | 44.20x | 32.95x | 28.98x |
| TransMedics Group, Inc. (TMDX)vs › | $2.99B | 42.79x | 70.56x | 92.49x | 92.49x |
| Doximity, Inc. (DOCS)vs › | $4.88B | 15.43x | 23.27x | 34.76x | 48.24x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.10B | 26.87x | 21.51x | 36.54x | 41.31x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.59B | N/A | 29.52x | 29.52x | 29.52x |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.24B | 79.88x | 89.40x | 72.51x | 73.89x |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
